Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 735,739 | reported | 16 Apr 2026 | tx 136+2,673,860−3,903,559.21 |
| BIOMARIN PHARMACEUTICAL INC | 39,621 | reported | 02 Mar 2009 | tx 214+828,703−621,668 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Apr 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 76,745 | 0.00 USD | |
| 16 Apr 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 132,693 | 0.00 USD | deriv |
| 02 Mar 2026 | SALE | Ultragenyx Pharmaceutical Inc. | 54,404 | 22.80 USD | |
| 01 Mar 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 71,177 | 0.00 USD | |
| 28 Feb 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 25,000 | 42.48 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 107,292 | 0.00 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 43,268 | 0.00 USD | |
| 03 Mar 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 73,434 | 42.10 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 78,448 | 0.00 USD | deriv |
| 30 Dec 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 11,727 | 42.23 USD | |
| 09 Dec 2024 | GIFT | Ultragenyx Pharmaceutical Inc. | 20,000 | 0.00 USD | |
| 10 Dec 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 8,273 | 50.00 USD | |
| 03 Sept 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 20,000 | 55.85 USD | |
| 06 Aug 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 20,000 | 50.17 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 38,428 | 0.00 USD | |
| 01 Mar 2024 | TAX_WITHHOLDING | Ultragenyx Pharmaceutical Inc. | 17,417 | 53.69 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 3,132 | 0.00 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 70,094 | 0.00 USD | deriv |
| 07 Feb 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 30,000 | 45.00 USD | |
| 29 Dec 2023 | SALE | Ultragenyx Pharmaceutical Inc. | 30,000 | 47.87 USD | |
| 19 Oct 2023 | EXERCISE | Ultragenyx Pharmaceutical Inc. | 47,853 | 6.86 USD | |
| 19 Oct 2023 | SALE | Ultragenyx Pharmaceutical Inc. | 47,853 | 33.52 USD | |
| 19 Oct 2023 | EXERCISE | Ultragenyx Pharmaceutical Inc. | 47,853 | 0.00 USD | deriv |
| 01 Mar 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 46,200 | 0.00 USD | |
| 01 Mar 2023 | TAX_WITHHOLDING | Ultragenyx Pharmaceutical Inc. | 16,140 | 45.65 USD |
3 purchases reported after at least 12 months of silence — most recent on 11 Sept 2019.